JP2015527875A5 - - Google Patents

Download PDF

Info

Publication number
JP2015527875A5
JP2015527875A5 JP2015516469A JP2015516469A JP2015527875A5 JP 2015527875 A5 JP2015527875 A5 JP 2015527875A5 JP 2015516469 A JP2015516469 A JP 2015516469A JP 2015516469 A JP2015516469 A JP 2015516469A JP 2015527875 A5 JP2015527875 A5 JP 2015527875A5
Authority
JP
Japan
Prior art keywords
seq
nucleotide sequence
st6galnac3
c1orf114
hapln3
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015516469A
Other languages
English (en)
Japanese (ja)
Other versions
JP6242388B2 (ja
JP2015527875A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/DK2013/050196 external-priority patent/WO2013185779A2/en
Publication of JP2015527875A publication Critical patent/JP2015527875A/ja
Publication of JP2015527875A5 publication Critical patent/JP2015527875A5/ja
Application granted granted Critical
Publication of JP6242388B2 publication Critical patent/JP6242388B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015516469A 2012-06-14 2013-06-14 前立腺ガンのバイオマーカー Active JP6242388B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201270326 2012-06-14
DKPA201270326 2012-06-14
PCT/DK2013/050196 WO2013185779A2 (en) 2012-06-14 2013-06-14 Biomarkers for prostate cancer

Publications (3)

Publication Number Publication Date
JP2015527875A JP2015527875A (ja) 2015-09-24
JP2015527875A5 true JP2015527875A5 (https=) 2016-07-07
JP6242388B2 JP6242388B2 (ja) 2017-12-06

Family

ID=48740787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015516469A Active JP6242388B2 (ja) 2012-06-14 2013-06-14 前立腺ガンのバイオマーカー

Country Status (6)

Country Link
US (1) US10106854B2 (https=)
EP (1) EP2861759B1 (https=)
JP (1) JP6242388B2 (https=)
AU (1) AU2013275761B2 (https=)
CA (1) CA2876252A1 (https=)
WO (1) WO2013185779A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902916C (en) 2013-03-14 2018-08-28 Mayo Foundation For Medical Education And Research Detecting neoplasm
EP3037545A1 (en) * 2014-12-23 2016-06-29 The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of the Holy & Undiv. Trinity of Queen Elizabeth near Dublin A DNA-methylation test for prostate cancer
US10435755B2 (en) 2015-03-27 2019-10-08 Exact Sciences Development Company, Llc Detecting esophageal disorders
CN114574585A (zh) 2015-08-31 2022-06-03 梅约医药教育及研究基金会 检测胃肿瘤
CN106480169B (zh) * 2015-09-01 2019-10-08 杨小丽 人aqp10和sox17基因甲基化位点的检测和应用
JP7356349B2 (ja) 2017-02-28 2023-10-04 マヨ ファウンデーション フォア メディカル エデュケーション アンド リサーチ 前立腺癌検出
GB201816820D0 (en) 2018-10-16 2018-11-28 Univ York Diagnostic method
EP3880846B1 (en) 2018-11-13 2024-08-28 Bracco Imaging SPA Gene signatures for the prediction of prostate cancer recurrence
CN109468381B (zh) * 2018-11-19 2022-11-25 兰州市第一人民医院 用于宫颈癌筛查的甲基化位点及其检测引物
US20220267858A1 (en) * 2019-07-19 2022-08-25 Vinius University Characterization of prostate cancer using dna methylation assay system
CN113122633A (zh) * 2020-01-14 2021-07-16 上海鹍远生物技术有限公司 检测dna甲基化的试剂及用途
AU2021268631A1 (en) * 2020-05-04 2023-01-05 Mayo Foundation For Medical Education And Research Detecting pancreatic neuroendocrine tumors
US20230212684A1 (en) * 2020-05-05 2023-07-06 The Board Of Trustees Of The Leland Stanford Junior University Cell-free dna biomarkers and their use in diagnosis, monitoring response to therapy, and selection of therapy for prostate cancer
CN118685523B (zh) * 2024-08-26 2024-11-15 湖南宏雅基因技术有限公司 一种用于前列腺癌检测的生物标志物组合、引物探针组合物及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6605432B1 (en) 1999-02-05 2003-08-12 Curators Of The University Of Missouri High-throughput methods for detecting DNA methylation
ATE429511T1 (de) * 2001-03-01 2009-05-15 Epigenomics Ag Verfahren zur entwicklung von gensätzen zu diagnostischen und therapeutischen zwecken auf grundlage des expressions- und methylierungsstatus der gene
US20100297067A1 (en) * 2007-05-14 2010-11-25 The Johns Hopkins University Methylation markers for prostate cancer and methods of use
EP2329041A1 (en) * 2008-08-05 2011-06-08 Veridex, LLC Prostate cancer methylation assay
WO2010080933A1 (en) 2009-01-07 2010-07-15 Myriad Genetics, Inc Cancer biomarkers
US20100303795A1 (en) 2009-05-27 2010-12-02 Soerensen Karina Dalsgaard Marker of prostate cancer
WO2011027310A1 (en) * 2009-09-03 2011-03-10 Koninklijke Philips Electronics N.V. Novel tumor markers
WO2011037936A2 (en) * 2009-09-24 2011-03-31 Oregon Health & Science University Detection of dna methylation of tal1, erg and/or cd40 to diagnose prostate cancer
WO2011044902A1 (en) 2009-10-13 2011-04-21 Aarhus Universitet Tff3 hypomethylation as a novel biomarker for prostate cancer
WO2011112845A2 (en) * 2010-03-11 2011-09-15 Board Of Regents, The University Of Texas System Methods and compositions related to a multi-methylation assay to predict patient outcome
WO2012138609A2 (en) * 2011-04-04 2012-10-11 The Board Of Trustees Of The Leland Stanford Junior University Methylation biomarkers for diagnosis of prostate cancer

Similar Documents

Publication Publication Date Title
JP2015527875A5 (https=)
Zhang et al. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling
JP6246845B2 (ja) 遺伝子発現を用いた前立腺癌の予後を定量化する方法
RU2718647C2 (ru) Медицинский прогноз и предсказание результатов лечения, используя активности множества клеточных сигнальных путей
JP6449779B2 (ja) 目的遺伝子発現の線形結合を用いた細胞信号伝達経路活性の評価
US9068974B2 (en) Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
CN103733065A (zh) 用于癌症的分子诊断试验
AU2016200494A1 (en) Molecular diagnostic test for cancer
JP2016536001A (ja) 肺がんのための分子診断試験
Liu et al. Diagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancer
CN114594259B (zh) 一种新型的用于结直肠癌预后预测和诊断的模型及其应用
JP2015536667A (ja) 癌のための分子診断検査
JP2011500071A (ja) 遺伝子に基づくアルゴリズム的ガン予後及び患者の臨床結果
WO2015033172A1 (en) Molecular diagnostic test for oesophageal cancer
CN101173313B (zh) 乳腺癌转移和预后分子分型基因群及其基因芯片制备和应用方法
EP3409794A1 (en) Circulating mirnas as early detection marker and prognostic marker
CN113736879A (zh) 用于小细胞肺癌患者预后的系统及其应用
WO2023014297A2 (en) Circulating microrna panel for the early detection of breast cancer and methods thereof
Azadeh et al. Decreased expression level of long non-coding RNA CCAT1, was observed in breast cancer tissue of an Isfahanian population (Iran)
CN108728534A (zh) 4-LncRNA分子标签用于肝癌预后评估的试剂盒
CN112063714A (zh) 一种与结直肠癌相关的miRNA及其应用
WO2014111561A1 (en) Serum mirna-142-3p as prognostic cancer marker
JP2020528733A (ja) 肝細胞癌(hcc)または胆管癌(cca)を有する被験者の生存転帰を予測する方法
CN113826166A (zh) 评估气道上皮细胞中的多信号传导途径活性评分以预测气道上皮异常和气道癌风险
US20240093306A1 (en) Micro rna liver cancer markers and uses thereof